Tags

Type your tag names separated by a space and hit enter

Percutaneous endoscopic gastrostomy (PEG) - a long-term follow-up study in head and neck cancer patients.
Clin Otolaryngol Allied Sci. 2004 Dec; 29(6):740-6.CO

Abstract

Many patients with head and neck cancer experience problems related to swallowing. A retrospective study of 156 consecutive patients who received a percutaneous endoscopic gastrostomy (PEG) at a teaching hospital is presented. The results showed that 42% had complications. Fatal complications were seen in connection with PEG tube placement, but severe and minor complications could occur much later. The method of PEG tube insertion did not affect the complication rates. The spectrum of observed complications is different to that reported earlier, suggesting that the learning curve of surgeons under training could have influenced the outcome. It may be concluded that for a very sick patient a theoretically easy surgical procedure could turn into a potentially dangerous operation. It is important to select suitable candidates for a PEG. Head and neck cancer patients with a PEG need special attention in connection with the PEG tube placement and also in a long perspective, e.g. by follow-up at a nurse-led outpatient clinic.

Authors+Show Affiliations

Department of Otolaryngology and Head & Neck Surgery, Karolinska Hospital, Stockholm, Sweden. ytiblom@hotmail.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15533171

Citation

Ehrsson, Y T., et al. "Percutaneous Endoscopic Gastrostomy (PEG) - a Long-term Follow-up Study in Head and Neck Cancer Patients." Clinical Otolaryngology and Allied Sciences, vol. 29, no. 6, 2004, pp. 740-6.
Ehrsson YT, Langius-Eklöf A, Bark T, et al. Percutaneous endoscopic gastrostomy (PEG) - a long-term follow-up study in head and neck cancer patients. Clin Otolaryngol Allied Sci. 2004;29(6):740-6.
Ehrsson, Y. T., Langius-Eklöf, A., Bark, T., & Laurell, G. (2004). Percutaneous endoscopic gastrostomy (PEG) - a long-term follow-up study in head and neck cancer patients. Clinical Otolaryngology and Allied Sciences, 29(6), 740-6.
Ehrsson YT, et al. Percutaneous Endoscopic Gastrostomy (PEG) - a Long-term Follow-up Study in Head and Neck Cancer Patients. Clin Otolaryngol Allied Sci. 2004;29(6):740-6. PubMed PMID: 15533171.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Percutaneous endoscopic gastrostomy (PEG) - a long-term follow-up study in head and neck cancer patients. AU - Ehrsson,Y T, AU - Langius-Eklöf,A, AU - Bark,T, AU - Laurell,G, PY - 2004/11/10/pubmed PY - 2005/3/23/medline PY - 2004/11/10/entrez SP - 740 EP - 6 JF - Clinical otolaryngology and allied sciences JO - Clin Otolaryngol Allied Sci VL - 29 IS - 6 N2 - Many patients with head and neck cancer experience problems related to swallowing. A retrospective study of 156 consecutive patients who received a percutaneous endoscopic gastrostomy (PEG) at a teaching hospital is presented. The results showed that 42% had complications. Fatal complications were seen in connection with PEG tube placement, but severe and minor complications could occur much later. The method of PEG tube insertion did not affect the complication rates. The spectrum of observed complications is different to that reported earlier, suggesting that the learning curve of surgeons under training could have influenced the outcome. It may be concluded that for a very sick patient a theoretically easy surgical procedure could turn into a potentially dangerous operation. It is important to select suitable candidates for a PEG. Head and neck cancer patients with a PEG need special attention in connection with the PEG tube placement and also in a long perspective, e.g. by follow-up at a nurse-led outpatient clinic. SN - 0307-7772 UR - https://www.unboundmedicine.com/medline/citation/15533171/Percutaneous_endoscopic_gastrostomy__PEG____a_long_term_follow_up_study_in_head_and_neck_cancer_patients_ DB - PRIME DP - Unbound Medicine ER -